Mercedes F1 Making a Significant Impact in Helping Coronavirus Patients

A breathing aid that helps keep Covid-19 patients out of intensive care has been created by mechanical designers, doctors, and the Mercedes F1 group.

The device, known as continuous positive airway pressure(CPAP), is in use broadly in Italy and China to help coronavirus patients. It overcomes any issues between a breathing device and the requirement for full ventilation, which requires sedation and an intrusive system.

A group from University College London (UCL) and University College London Hospital (UCLH) have worked with Mercedes F1. In addition, It works to adjust and improve existing CPAP in a procedure known as reverse engineering. The MHRA now suggests the use of the device, which approves clinical gadgets in the UK, UCL said.

The device is put together in less than 100 hours. It includes the underlying gathering to the creation of the first CPAP.

The Mercedes AMG’s HPP division in Brixworth provides assistance to manufacture the device. Although, It is the unit that structures and assembles the group’s hybrid motors.

Mercedes F1 works towards ‘Project Pitlane’

Mercedes F1 has so far conveyed 40 CPAP gadgets to UCLH. However, a coordinated exertion by the F1 community called ‘Project Pitlane’ will take into account the creation of 1,000 units every day if preliminaries work out in a good way.

“The Formula 1 community has shown an impressive response to the call for support, coming together in the ‘Project Pitlane’ collective to support the national need at this time across a number of different projects,” explained Mercedes-AMG Powertrains boss Andy Cowell.

“We are proud to put our resources at the service of UCL to deliver the CPAP project.  And in the fastest possible timeframe.”

Professor David Lomas praised the efforts and speed with which the device has been produced. He said “I would like to pay tribute to the incredible team of engineers and clinicians at UCL, HPP, and UCLH, for working round-the-clock to develop this new prototype.

“It is, quite simply, a wonderful achievement to have gone from first meeting to regulator approval in just 10 days. It shows what can be done when universities, industry, and hospitals join forces for the national good.”